Regional Analysis
Global Single-cell Omics Market Regional Insights
- North America is accounted for the largest market share of over 55% in 2023, and is projected to remain dominant over the forecast period. The high prevalence of cancer, the presence of key market players are the key factors driving the growth of the market in this region.
- Europe is the second-largest market for single-cell omics. Increasing product launches. Market players are focusing on organic strategies is expected to aid in the market growth over the forecast period.
- Asia Pacific is the fastest-growing market for single-cell omics due to research and developmental (R&D) activities by the market players is expected to drive the market growth over the forecast period
Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: South Africa, Central Africa, North Africa
|